Literature DB >> 8985354

Biochemical and functional analysis of the Borna disease virus G protein.

P A Schneider1, C G Hatalski, A J Lewis, W I Lipkin.   

Abstract

The Borna disease virus (BDV) antigenome is comprised of five major open reading frames (ORFs). Products have been reported only for ORFs I, II, and III, encoding N (p40), P (p24/p23), and M (gp18), respectively. ORF IV predicts a 57-kDa protein with several potential glycosylation sites. Analysis of radiolabeled extracts from BDV-infected C6 cells and BHK-21 cells transfected with a Semliki Forest virus vector that contains ORF IV demonstrated the presence of a 94-kDa protein (G protein) which was sensitive to tunicamycin, endoglycosidase F/N-glycosidase, and endoglycosidase H but not to O-glycosidase. Sera from BDV-infected rats detected the G protein and had neutralization activity that was reduced following immunoadsorption with the G protein. Preincubation of cells with the G protein interfered with BDV infectivity. This effect was enhanced by treatment of the G protein with the exoglycosidase alpha-mannosidase and reduced after subsequent treatment with N-acetyl-beta-D-glucosaminidase. In concert these findings indicate that ORF IV encodes a 94-kDa N-linked glycoprotein with extensive high mannose- and/or hybrid-type oligosaccharide modifications. The presence of neutralization epitopes on the G protein and its capacity to interfere with infectivity suggest that the G protein is important for viral entry.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985354      PMCID: PMC191055     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  endo-beta-N-Acetylglucosaminidase from Streptomyces plicatus.

Authors:  A L Tarentino; R B Trimble; F Maley
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

Review 2.  Borna disease: a persistent virus infection of the central nervous system.

Authors:  H Ludwig; L Bode; G Gosztonyi
Journal:  Prog Med Virol       Date:  1988

3.  Focus-immunoassay for Borna disease virus-specific antigens.

Authors:  G Pauli; J Grunmach; H Ludwig
Journal:  Zentralbl Veterinarmed B       Date:  1984-08

4.  Borna disease in a sheep.

Authors:  R O Waelchli; F Ehrensperger; A Metzler; C Winder
Journal:  Vet Rec       Date:  1985-11-09       Impact factor: 2.695

5.  The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.

Authors:  L K Hawkins; W S Wold
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

6.  Borna disease in rhesus monkeys as a models for uveo-cerebral symptoms.

Authors:  L Stitz; H Krey; H Ludwig
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

7.  Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders.

Authors:  R Rott; S Herzog; B Fleischer; A Winokur; J Amsterdam; W Dyson; H Koprowski
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

8.  Isolation and characterization of a 14500 molecular weight protein from brains and tissue cultures persistently infected with borna disease virus.

Authors:  R Schädler; H Diringer; H Ludwig
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

9.  Intracellular appearance of a glycoprotein in VSV-infected BHK cells lacking the membrane-anchoring oligopeptide of the viral G-protein.

Authors:  C Garreis-Wabnitz; J Kruppa
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

10.  O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus.

Authors:  D C Johnson; P G Spear
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

View more
  24 in total

1.  Expression and characterization of the Borna disease virus polymerase.

Authors:  M P Walker; I Jordan; T Briese; N Fischer; W I Lipkin
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Implication of a cis-acting element in the cytoplasmic accumulation of unspliced Borna disease virus RNAs.

Authors:  P A Schneider; M Schwemmle; W I Lipkin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin.

Authors:  J A Richt; T Fürbringer; A Koch; I Pfeuffer; C Herden; I Bause-Niedrig; W Garten
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Evidence for translation of the Borna disease virus G protein by leaky ribosomal scanning and ribosomal reinitiation.

Authors:  P A Schneider; R Kim; W I Lipkin
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry.

Authors:  Sarah Murray; Carol L Nilsson; Joan T Hare; Mark R Emmett; Andrei Korostelev; Heather Ongley; Alan G Marshall; Michael S Chapman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Open reading frame III of borna disease virus encodes a nonglycosylated matrix protein.

Authors:  I Kraus; M Eickmann; S Kiermayer; H Scheffczik; M Fluess; J A Richt; W Garten
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Borna disease virus nucleoprotein requires both nuclear localization and export activities for viral nucleocytoplasmic shuttling.

Authors:  T Kobayashi; W Kamitani; G Zhang; M Watanabe; K Tomonaga; K Ikuta
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  The use of peptide arrays for the characterization of monospecific antibody repertoires from polyclonal sera of psychiatric patients suspected of infection by Borna Disease Virus.

Authors:  Martin Schwemmle; Christian Billich
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

9.  Effect of immune priming on Borna disease.

Authors:  A J Lewis; J L Whitton; C G Hatalski; H Weissenböck; W I Lipkin
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Authors:  O Planz; L Stitz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.